If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
NOVATO, Calif., Nov. Thirty (HSMN NewsFeed) — BioMarin Laboratory Inc. (Nasdaq: BMRN ) announced today that the Food and Drug Administration (FDA) has granted orphan drug designation for THREE,4-diaminopyridine (3,4-DAP), amifampridine phosphate, for the ra…
Biopharmaceuticals, FDA
BioMarin Lab, 3,4-diaminopyridine, Lambert Eaton Myasthenic Syndrome
Posts from ‘November, 2009’
FDA Grants Orphan Drug Designation for THREE,4-DAP for LEMS
Depomed Files Patent Infringement Lawsuit Against Lupin Limited
MENLO PARK, Calif.–(HSMN NewsFeed)–Depomed, Inc. (Nasdaq:DEPO ) today announced that it has filed a lawsuit in the United States District Court for the Northern District of California against Lupin Limited and its wholly-owned subsidiary, Lupin Pharmaceu…
Biopharmaceuticals, Generics, Litigation, FDA
Depomed, Lupin Pharmaceuticals, GLUMETZA, metformin
sanofi-aventis U.S. and Intelliject, Inc. Sign Licensing Agreement for Novel Epinephrine Auto Injector in North America
BRIDGEWATER, N.J., Nov. 30 (HSMN NewsFeed) — sanofi-aventis U.S. announced today the signing of an exclusive licensing agreement with Intelliject, Inc. for a novel epinephrine auto injector for the emergency treatment of allergic reactions (anaphylaxis)…
Devices, Biopharmaceuticals, Drug Delivery, Licensing
sanofi-aventis, Intelliject, epinephrine, injector
Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer’s Disease
WAYNE, N.J. and CHICAGO, Nov. 30 (HSMN NewsFeed) — Today at the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced the enrollment of the first patient in an in…
Biopharmaceuticals, Devices, Radiology, Neurology
Bayer HealthCare, florbetaben, PET imaging, amyloid, Alzheimer’s
Philips Helps Hospitals Strike Balance Between Innovation and Value
Responding directly to customer concerns, Philips’ latest healthcare solutions address financial needs by leveraging innovation CHICAGO, Nov. 27 (HSMN NewsFeed) — At the upcoming Radiological Society of North America (RSNA) annual meeting starting Su…
Devices, Radiology
Royal Philips Electronics, imaging
Varian Laboratory Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago
SALT LAKE CITY, Nov. 27 (HSMN NewsFeed) — Booth - 3646/South Hall A - Varian Clinical laboratory Systems, Inc. (NYSE: VAR ), a premier supplier of X-ray tubes and flat panel digital image detectors, will exhibit its full range of detectors at the RSNA Annual Meetin…
Devices, Radiology, Oncology
Varian Laboratory Systems, imaging, radiotherapy
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
SOUTH SAN FRANCISCO, CA - (HSMN NewsFeed) - Theravance, Inc. (NASDAQ:THRX ) announced today that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) related to the telavancin New Drug Application (NDA) for the treatment …
Biopharmaceuticals, FDA
Theravance, Telavancin, nosocomial pneumonia, nosocomial, antibiotic
STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe
PARIS, November 27 (HSMN NewsFeed) — Stallergenes has been granted European approval to market Oralair® in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair® has been marketed, was the refe…
Biopharmaceuticals, Regulatory
Stallergenes, Oralair
Quantum Immunologics Announces Collaboration With Auburn University Veterinary College to Commercialize Veterinary Cancer Immunotherapy
TAMPA, FL - (HSMN NewsFeed) - Quantum Immunologics, Inc. (QI), a privately held biotechnology company, announced today that it has entered into a Collaboration Agreement with Auburn University to bring its novel cancer immunotherapy to the veterinary marke…
Biopharmaceuticals, Oncology
Quantum Immunologics, immunotherapy
U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine)
BRIDGEWATER, N.J., Nov. 25 (HSMN NewsFeed) — The FDA granted traditional approval for INTELENCE(R) (etravirine) tablets, a non-nucleoside reverse transcriptase inhibitor (NNRTI). INTELENCE is the only NNRTI specifically indicated for use in treatment-ex…
Biopharmaceuticals, HIV/AIDS, FDA
Tibotec Therapeutics, Centocor Ortho Biotech, INTELENCE, etravirine
